Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid Application Methods in Gynecomastia Surgery
NCT06509256Phase 1Not yet recruiting
- Sponsor
- Assiut University
- Start
- Jul 2024
- Primary completion
- Jul 2024
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of tranexamic acid in gynecomastia (3 arms), sponsored by Assiut University. Primary endpoint: Intraoperative blood loss during liposuction. Planned start Jul 2024; status: not yet recruiting.
02
Drugs
tranexamic acid
03
Conditions
gynecomastia
Beyond the preview
Go deeper on NCT06509256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06509256.